MSH2 Gene

• The MSH2 gene is a vital component of the DNA mismatch repair (MMR) system, responsible for correcting errors that occur during DNA replication.
• Mutations in the MSH2 gene impair the MMR system, leading to an accumulation of genetic errors and significantly increasing an individual’s risk of developing various cancers.
• A primary consequence of MSH2 gene mutations is Lynch syndrome, a hereditary condition that predisposes individuals to colorectal, endometrial, and other cancers.
• Genetic testing for MSH2 mutations is crucial for individuals with a family history of Lynch syndrome or early-onset cancers to assess risk and guide surveillance strategies.

What is the MSH2 Gene: Function and Purpose

The MSH2 gene is a human gene located on chromosome 2, encoding a protein that is a key component of the DNA mismatch repair (MMR) system. This system is crucial for correcting errors that spontaneously arise during DNA replication, ensuring the fidelity of genetic information passed from one cell generation to the next. The primary MSH2 gene function and purpose is to recognize and bind to mismatched base pairs and small insertion-deletion loops that escape the proofreading activity of DNA polymerases.

Once MSH2, often in a complex with MSH6 (forming MutSα) or MSH3 (forming MutSβ), identifies a DNA error, it recruits other proteins to the site. This initiates a cascade of events that ultimately leads to the excision of the incorrect DNA segment and its resynthesis with the correct bases. This meticulous repair process is vital because even minor errors in DNA can lead to significant cellular dysfunction or uncontrolled cell growth. Without a properly functioning MSH2 protein, the cell’s ability to correct these errors is severely compromised, allowing mutations to accumulate.

MSH2 Gene Mutations and Their Effects

Mutations in the MSH2 gene can have profound consequences for an individual’s health, primarily by compromising the integrity of the DNA mismatch repair system. When the MSH2 protein is non-functional or absent due to a pathogenic mutation, the cell loses its ability to effectively repair DNA replication errors. The direct MSH2 gene mutation effects include an increased rate of spontaneous mutations throughout the genome, a phenomenon known as microsatellite instability (MSI).

This accumulation of mutations can affect critical genes involved in cell growth, differentiation, and programmed cell death. Over time, these genetic alterations can drive the transformation of normal cells into cancerous ones. Individuals inheriting a mutated copy of the MSH2 gene are predisposed to developing various cancers at an earlier age and often in multiple primary sites. The specific types of cancers are often linked to the tissues with high cell turnover, where replication errors are more frequent.

MSH2 Gene and Lynch Syndrome

A significant consequence of inheriting a pathogenic mutation in the MSH2 gene is the development of Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC). This is an autosomal dominant inherited condition, meaning that only one copy of the mutated gene is needed to increase cancer risk. Mutations in MSH2 are among the most common causes of Lynch syndrome, accounting for a substantial proportion of cases alongside mutations in MLH1, MSH6, and PMS2 genes.

The MSH2 gene and Lynch syndrome connection is well-established, with carriers facing a significantly elevated lifetime risk of developing several types of cancer. According to the National Cancer Institute, individuals with Lynch syndrome have up to an 82% lifetime risk of colorectal cancer and up to a 60% lifetime risk of endometrial cancer, compared to the general population. Other cancers associated with Lynch syndrome include:

• Ovarian cancer
• Stomach cancer
• Small intestine cancer
• Hepatobiliary tract cancer
• Urinary tract cancer
• Brain cancer
• Skin cancer (sebaceous adenomas, sebaceous carcinomas, keratoacanthomas)

Early detection and regular surveillance, such as colonoscopies starting at a younger age, are crucial for individuals diagnosed with MSH2-related Lynch syndrome to manage their cancer risk effectively. Genetic counseling and testing are recommended for individuals with a family history suggestive of Lynch syndrome to identify carriers and implement appropriate preventative and screening measures.